J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 22.14 CNY 0.64% Market Closed
Market Cap: 17.7B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Jafron Biomedical Co Ltd stock under the Base Case scenario is 43.19 CNY. Compared to the current market price of 22.14 CNY, Jafron Biomedical Co Ltd is Undervalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
43.19 CNY
Undervaluation 49%
Relative Value
Price
J
Worst Case
Base Case
Best Case

Valuation Multiples

6.8
P/S
P/S
Price to Sales
6.8
vs History
98
vs Industry
16
Median 3Y
9.4
Median 5Y
11.5
Industry
2.2
Forward
5.9
More Details
22.2
P/E
P/E
Price to Earnings
22.2
vs History
95
vs Industry
22
Median 3Y
30.2
Median 5Y
36.2
Industry
21.8
Forward
16.3
More Details
14.9
P/OCF
P/OCF
Price to OCF
14.9
vs History
98
vs Industry
22
Median 3Y
20.5
Median 5Y
29
Industry
13.4
More Details
24
P/FCFE
P/FCFE
Price to FCFE
24
vs History
68
vs Industry
16
Median 3Y
24.9
Median 5Y
33
Industry
19
More Details
5.9
P/B
P/B
Price to Book Value
5.9
vs History
84
vs Industry
10
Median 3Y
7
Median 5Y
8.7
Industry
2.1
More Details
6.4
EV/S
EV/S
Enterprise Value to Sales
6.4
vs History
98
vs Industry
15
Median 3Y
8.9
Median 5Y
10.9
Industry
2.3
Forward
5.5
More Details
8
EV/GP
EV/GP
Enterprise Value to Gross Profit
8
vs History
98
vs Industry
22
Median 3Y
11.3
Median 5Y
13.1
Industry
4.8
More Details
16.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.7
vs History
98
vs Industry
17
Median 3Y
24.3
Median 5Y
28.6
Industry
11.4
Forward
12.5
More Details
16.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.7
vs History
98
vs Industry
22
Median 3Y
24.3
Median 5Y
28.6
Industry
15.5
Forward
14.1
More Details
14
EV/OCF
EV/OCF
Enterprise Value to OCF
14
vs History
96
vs Industry
24
Median 3Y
19.6
Median 5Y
28
Industry
13.3
More Details
19.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.2
vs History
92
vs Industry
20
Median 3Y
26.9
Median 5Y
50.7
Industry
17.1
More Details
6.5
EV/IC
EV/IC
Enterprise Value to IC
6.5
vs History
87
vs Industry
10
Median 3Y
8.2
Median 5Y
12.8
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Jafron Biomedical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jafron Biomedical Co Ltd
SZSE:300529
17.9B CNY 6.8 22.2 16.7 16.7
US
Abbott Laboratories
NYSE:ABT
223.1B USD 5.3 16.5 21.5 30.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.3B USD 21 74 59 71
US
Boston Scientific Corp
NYSE:BSX
150.3B USD 8.6 73.9 34.9 48.4
US
Stryker Corp
NYSE:SYK
139.2B USD 6.2 46.5 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
108B USD 3.3 25.4 13.6 19.2
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.3 26.4 15.3 21.8
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD 2.9 34 14.5 26.1
US
Edwards Lifesciences Corp
NYSE:EW
44.8B USD 8.1 10.7 24.5 27
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.7B USD 9.2 40.2 28.6 31.9

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 250,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.